Cvs Pharmacy #02173 Durable Medical Equipment & Medical Supplies Location: 306 E Baltimore Pike Avenue, Media, Pennsylvania 19063 Phone: (610) 566-8400 |
Cvs Pharmacy #07239 Durable Medical Equipment & Medical Supplies Location: 3 S Pennell Rd, Media, Pennsylvania 19063 Phone: (610) 565-7720 |
Rite Aid Pharmacy 11113 Durable Medical Equipment & Medical Supplies Location: 510 E Baltimore Pike, Media, Pennsylvania 19063 Phone: (610) 566-3218 |
Elwyn Pharmacy DME Supplier - Customized Equipment Location: 194 S Middletown Rd, Media, Pennsylvania 19063 Phone: (610) 566-2226 |
Murray Overhill Pharmacy Medicare Supplier Location: 32 W State St, Media, Pennsylvania 19063 Phone: (610) 566-2345 |
Sav-on Pharmacy #2876 Durable Medical Equipment & Medical Supplies Location: 1067 W Baltimore Pike, Media, Pennsylvania 19063 Phone: (610) 627-0521 |
Sav-on Pharmacy #0809 Durable Medical Equipment & Medical Supplies Location: 527 E Baltimore Pike, Media, Pennsylvania 19063 Phone: (610) 565-0657 |
News Archive
There's a reason soldiers go through basic training before heading into combat: Without careful instruction, green recruits armed with powerful weapons could be as dangerous to one another as to the enemy.
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius released the following statement today on WellPoint's announcement that it intends to end the practice of rescinding patients' coverage in advance of the Affordable Care Act's requirement that insurers stop this practice starting this fall. WellPoint's announcement comes after Secretary Sebelius sent a letter on April 22 urging the company to immediately stop the practice of rescinding coverage for patients who become ill.
MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM ‘19, (European Association of Nuclear Medicine) last week in Barcelona. The range comprising four models, including a small benchtop PET/CT, can accommodate small animals up to 12 kg.
While the H1N1 global pandemic may not have resulted in as many severe cases as originally predicted, a new study released today by the Canadian Institute for Health Information (CIHI) shows that more than 15,000 Canadians were admitted to hospital for H1N1 in Canada between April and December 2009.
The Swedish biotech company Karo Bio today announced that Merck & Co., Inc., through an affiliate, plans to enter a clinical phase IIa trial with the collaboration's lead investigational drug candidate, MK-6913, identified as part of their joint research collaboration. No milestone payment to Karo Bio is associated with the initiation of phase II clinical development.
› Verified 7 days ago